
Brian P Brooks MD PhD
Pediatric & Strabismus
Chief, Ophthalmic Genetics & Visual Function Branch National Eye Insitute, NIH
Join to view full profile
10 Center DriveBldg. 10, Rm. 10N109, MSC 1860Bethesda, MD 20892
Phone+1 301-496-3577
Fax+1 301-402-1214
Dr. Brooks is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterResidency, Medical Genetics and Genomics, 2002 - 2004
University of Michigan Health SystemResidency, Ophthalmology, 1998 - 2001
Graduate HospitalInternship, Internal Medicine, 1997 - 1998
Perelman School of Medicine at the University of PennsylvaniaClass of 1997
University of Michigan Health SystemFellowship, Pediatric Ophthalmology
Certifications & Licensure
DC State Medical License 2004 - 2027
MI State Medical License 1998 - 2005
PA State Medical License 1997 - 1998
American Board of Ophthalmology Ophthalmology
American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Clinical Trials
- Family Studies of Uveal Coloboma Start of enrollment: 2006 Jul 28
- Repository for Inherited Eye Diseases Start of enrollment: 2006 Sep 20
- Cell Collection to Study Eye Diseases Start of enrollment: 2011 Sep 07
Publications & Presentations
PubMed
- A peripheral subpopulation of retinal pigment epithelium resists oxidative damage through SERPINE3-mediated Caspase-1 inhibition.Huirong Li, Takerra Johnson-Stephenson, Vincent P Kunze, Wei Yan, David M McGaughey
The Journal of Clinical Investigation. 2026-07-07 - Ampyrone is a direct agonist of human tyrosinase and a potential therapeutic for hypopigmentation disorders.Monika B Dolinska, Yuhong A Wang, Nathan P Coussens, Vijay K Kalaskar, Zuhal Eraslan
JCI Insight. 2026-06-18 - Gene therapy induces pigmentation in induced pluripotent stem cell-derived retinal pigment epithelium of OCA1A patients and albino rat eye.Aman George, Arnold Leigh, Evan Selzer, Tyler Pfister, Charles DeYoung
Molecular Therapy. Advances. 2026-06-11
Journal Articles
- The Henle Fiber Layer in Albinism: Comparison to Normal and Relationship to Outer Nuclear Layer Thickness and Foveal Cone DensityDaniel J Lee, Brian P Brooks, Brandon J Lujan, Investigative Ophthalmology and Visual Science
- Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3Jessica S Albert, Brian P Brooks, Investigative Ophthalmology and Visual Science
Press Mentions
Discovery Could Lead to Drug Therapy for Hypopigmentation ConditionsJuly 14th, 2026
COVID Vaccine Live Updates: Here’s What to Know in North Carolina on Nov. 2November 2nd, 2021
COVID Vaccine Live Updates: Here’s What to Know in North Carolina on Nov. 1November 1st, 2021
Grant Support
- Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children (MAGIC) StudyEMORY UNIVERSITY2021–2026
- The Genetics Of Uveal ColobomaNational Eye Institute2009–2011
- Pre-Clinical Studies Of NTBC As A Potential Treatment For AlbinismNational Eye Institute2009–2011
- Ophthalmic Genetics FellowshipNational Eye Institute2009–2011
- Crx-Mediated Leber Congenital AmaurosisNational Eye Institute2009–2010
External Links
- NEI websitehttps://www.nei.nih.gov/intramural/staff/brooks
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









